Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

102.77USD
29 Sep 2016
Change (% chg)

$-3.06 (-2.89%)
Prev Close
$105.83
Open
$105.83
Day's High
$106.30
Day's Low
$102.28
Volume
5,545,237
Avg. Vol
4,292,712
52-wk High
$128.39
52-wk Low
$93.05

Kaplan, Gilla 

Dr. Gilla Kaplan, Ph.D. serves as Independent director of the Company, since April 1998. She is a member of the Nominating Committee and, until April 2015, was a member of the Audit Committee. Dr. Kaplan was appointed Director of the Global Health Program, Tuberculosis, at the Bill and Melinda Gates Foundation in January 2014. She previously served as Senior Advisor to the Global Health Program, Tuberculosis and member of the International Scientific Advisory Committee for the Global Health Program of the Bill and Melinda Gates Foundation. Dr. Kaplan was head of the Laboratory of Mycobacterial Immunity and Pathogenesis at The Public Health Research Institute Center at the New Jersey Medical School, Newark, New Jersey, where she was appointed full Member in 2002 and Assistant Director in 2006. Dr. Kaplan also was previously appointed, in 2005, Professor of Medicine at the University of Medicine and Dentistry of New Jersey. Prior to that, Dr. Kaplan was an immunologist in the Laboratory at Cellular Physiology and Immunology at The Rockefeller University in New York where she was an Associate Professor.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

22,472,900

Jacqualyn Fouse

8,073,500

Mark Alles

7,912,170

Peter Kellogg

5,705,640

Thomas Daniel

7,341,980

Scott Smith

4,783,240
As Of  30 Dec 2015